Source

British Journal of Clinical Pharmacology

2 developments in the corpus

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · JOURNAL ARTICLE

Alpha lipoic acid for prevention of radiation‐induced dermatitis in breast cancer patients: A randomized‐controlled trial

British Journal of Clinical Pharmacology

A single-centre RCT with modest sample size (n=40) and surrogate endpoint (dermatitis grading) showing benefit of ALA over control, needing confirmation in larger trials before clinical adoption.

PromisingSara Mahmoud Shaheen Chemotherapy-related Skin Toxicity Rana Mohamed Elsayed Kelany

Reported

Asymptomatic at week 2 (ALA vs co…90% vs 50%

Asymptomatic at week 3 (ALA vs co…60% vs 20%

Grade ≥2 RID incidence (ALA vs co…10% vs 45%

SEP 6, 2026 · JOURNAL ARTICLE

The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR‐TKIs treatment

British Journal of Clinical Pharmacology

Retrospective cohort study with adjusted hazard ratios showing substantial associations between H1-antihistamine use and improved TTF and mortality in NSCLC patients on EGFR-TKIs, but observational design precludes causal inference and requires prospective confirmation.

PromisingVan Thuan Nguyen Lung Cancer Treatments and Mutations Toan Trung Duong

Reported

Treatment failure hazard ratio (a…0.61

Treatment failure 95% CI0.53–0.71

Treatment failure p-value<.001